BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29369390)

  • 1. CDX2 and LEF-1 expression in pilomatrical tumors and their utility in the diagnosis of pilomatrical carcinoma.
    Tumminello K; Hosler GA
    J Cutan Pathol; 2018 May; 45(5):318-324. PubMed ID: 29369390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR; Jayachandran P; Chang DT; Pai R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDX2 expression in primary skin tumors-case series and review of the literature.
    Tekin B; Kundert P; Yang HH; Guo R
    Hum Pathol; 2022 Nov; 129():1-10. PubMed ID: 35926811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors.
    Pećina-Šlaus N; Kafka A; Tomas D; Marković L; Okštajner PK; Sukser V; Krušlin B
    Histol Histopathol; 2014 Dec; 29(12):1557-64. PubMed ID: 24858819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDX2 and SATB2 positivity in pilomatrix carcinoma: Avoiding an erroneous diagnosis of cutaneous metastasis of gastrointestinal origin.
    Kenny B; Osmond A
    J Cutan Pathol; 2022 Apr; 49(4):399-402. PubMed ID: 34797586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
    Chen PH; Bossuyt V; Reisenbichler E
    Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant Pilomatrical Tumor With Broad Epidermal Components: An Example of Histological Diversity and a Potential Diagnostic Pitfall of Tumors With Pilomatrical Differentiation.
    Terada K; Yamada Y; Fujimoto M; Usui S; Kogame T; Kaku Y; Moriyoshi K; Haga H
    Am J Dermatopathol; 2022 Feb; 44(2):129-134. PubMed ID: 34291738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Pilomatrix Carcinoma: A Case Report With Emphasis on Molecular Pathology and Review of the Literature.
    Kamil ZS; Sachdeva M; Kwapis J; Ghazarian D
    Cutis; 2021 Oct; 108(4):E24-E28. PubMed ID: 34847012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation and apoptosis in pilomatrixoma.
    Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
    Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEF-1 is a Sensitive Marker of Cribriform Morular Variant of Papillary Thyroid Carcinoma.
    Mohindra S; Sakr H; Sturgis C; Chute DJ
    Head Neck Pathol; 2018 Dec; 12(4):455-462. PubMed ID: 29243023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype.
    Rübben A; Wahl RU; Eggermann T; Dahl E; Ortiz-Brüchle N; Cacchi C
    PLoS One; 2020; 15(3):e0230003. PubMed ID: 32155193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomatoid pilomatrix carcinoma.
    Fernandez-Flores A; Cassarino DS
    J Cutan Pathol; 2018 Jul; 45(7):508-514. PubMed ID: 29624700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SATB2 Versus CDX2: A Battle Royale for Diagnostic Supremacy in Mucinous Tumors.
    Brettfeld SM; Ramos BD; Berry RS; Martin DR; Hanson JA
    Arch Pathol Lab Med; 2019 Sep; 143(9):1119-1125. PubMed ID: 30838879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple pilomatricomas: case presentation and review of the literature.
    Chan JJ; Tey HL
    Dermatol Online J; 2010 Apr; 16(4):2. PubMed ID: 20409409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Chiesa-Vottero A
    Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of LEF-1 in odontogenic and salivary tumors.
    Bilodeau EA; Acquafondata M; Barnes EL; Seethala RR
    Hum Pathol; 2015 Feb; 46(2):255-9. PubMed ID: 25497834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
    Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
    J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilomatrical Acanthoma: An Extremely Rare Intraepidermal Variant of Pilomatricoma.
    He L; Hosler GA
    Am J Dermatopathol; 2022 Jun; 44(6):433-436. PubMed ID: 35120037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.